GSK (NYSE:GSK) has reportedly made its first shipment of its malaria vaccine Mosquirix to Africa. A shipment of 331,200 doses of Mosquirix was delivered to Cameroon on Tuesday.

The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

New clinical trial data shows that the effectiveness of GlaxoSmithKline’s malaria vaccine decreases over time, with the vaccine protecting only 16.8% of children over four years. Phase 3 ...

joins GSK’s RTS,S/AS01 vaccine as the only two malaria vaccines endorsed by WHO. The four-dose R21 vaccine contains Novavax’s Matrix-M saponin-based adjuvant. The adjuvant makes the vaccine ...

The team think this helps the immune system to focus on malaria rather than the hepatitis. The success of the GSK vaccine has partly paved the way for Oxford to be optimistic of having their ...

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...

malaria, and others. In 2022, GSK’s 12 manufacturing sites in eight countries produced and delivered more than 500 million vaccine doses—one and a half million vaccine doses daily. Each year ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following ...

EMVI = European malaria vaccine initiative; GLURP = Glutamate-rich protein; GSK = GlaxoSmithKline; LSA = Liver-stage antigen; LSP = Long-synthetic peptide; ME-TRAP = Multiepitope-thrombospondin ...